Human carboxylesterase 1A2 expressed from carboxylesterase 1A1 and 1A2 genes is a potent predictor of CPT-11 cytotoxicity in vitro.
about
Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteinsIndividualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics.Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 yearsAssociation of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patientsCarboxylesterase 1 gene duplication and mRNA expression in adipose tissue are linked to obesity and metabolic functionRegulatory effects of genomic translocations at the human carboxylesterase-1 (CES1) gene locus.Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.Nonclinical pharmacokinetics of oseltamivir and oseltamivir carboxylate in the central nervous system.An overview of the recent progress in irinotecan pharmacogenetics.Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs.CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors.DNA methylation and its involvement in carboxylesterase 1A1 (CES1A1) gene expression.Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53.Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity.The effect of carboxylesterase 1 (CES1) polymorphisms on the pharmacokinetics of oseltamivir in humans.Carboxylesterase 1 (CES1) genetic polymorphisms and oseltamivir activation.The Pharmacokinetics of Enalapril in Relation to CES1 Genotype in Healthy Danish Volunteers.The impact of CES1 genotypes on the pharmacokinetics of methylphenidate in healthy Danish subjects.Clinical implications of genetic variation in carboxylesterase drug metabolism.
P2860
Q24601354-FFDF4A6E-B9D0-4A74-B260-4F4CE2326220Q30373969-4183E3BA-2AD8-4F33-B264-14079B10B600Q34008793-44D86C5B-BD19-4A2F-963D-BA2B9EFF1CDFQ34026252-FA3DAC2F-4E57-4A60-9F49-394E79ACBECCQ34611588-CF025760-0348-415F-B7C7-949755757EEDQ36767978-6D41ED9C-5BF5-4CC3-B859-59B85BFCC79CQ37331947-8E7388D4-4CAC-4833-8FF3-3089EA5AF05FQ37409972-5F58F6DE-CE3F-4BC5-B62E-370E6C03158DQ37710511-363D6D19-D78E-473A-9E2D-9C4341A7F13DQ37876401-C76E41E7-D022-45E5-9B39-38DA499789EEQ38863876-33884A81-3E12-4CE5-99FC-C5DB83C02533Q39750765-9D4971B4-992C-4D80-9D81-628ACEE8EFE4Q40286324-88342F18-50FE-4879-A35C-5A1808194E4AQ43145481-52CDF9A5-EEEB-45EA-9488-956742FFF7A7Q43882150-24682508-7FF3-478F-AB50-4B07A159E0B8Q46155415-537EFD91-16FF-4D67-BEE4-5C62F119D1AEQ47686935-5145BE20-8C6F-42A1-B13F-E11A35AD00B2Q47827847-9D96EB76-FBD5-41E5-9321-63756B48A523Q49628042-9E9C77A3-833D-4BA1-82FA-55EB8C547F6D
P2860
Human carboxylesterase 1A2 expressed from carboxylesterase 1A1 and 1A2 genes is a potent predictor of CPT-11 cytotoxicity in vitro.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Human carboxylesterase 1A2 exp ...... CPT-11 cytotoxicity in vitro.
@en
type
label
Human carboxylesterase 1A2 exp ...... CPT-11 cytotoxicity in vitro.
@en
prefLabel
Human carboxylesterase 1A2 exp ...... CPT-11 cytotoxicity in vitro.
@en
P2093
P1476
Human carboxylesterase 1A2 exp ...... CPT-11 cytotoxicity in vitro.
@en
P2093
Keiji Tanimoto
Keiko Hiyama
Masahiko Nishiyama
Mika Kaneyasu
Tatsushi Shimokuni
P356
10.1097/01.FPC.0000230110.18957.50
P577
2007-01-01T00:00:00Z